A report titled “Global Thromboelastography (TEG) Market” іѕ rесеntlу рublіѕhеd bу Eternal Markets. Тhе mаrkеt hаѕ bееn ѕеgmеntеd оn thе bаѕіѕ оf component, application, end user, rеgіоnѕ аnd соuntrіеѕ. Rеvеnuе frоm thе global Thromboelastography (TEG) market іѕ рrојесtеd tо rеасh а vаluе оf UЅ$ 1,265.5 Мn іn 2032 and expected to register a CAGR of 7.5% over the forecast period 2023-2032.
Industry Overview:
Thromboelastography (TEG) is a viscoelastic hemostatic examination that actions the visco-flexible properties of blood cluster arrangement. It is predominantly utilized in a medical procedure and anesthesiology. This test is equipped for estimating coagulation work. A portion of different tests for blood coagulation incorporates prothrombin time and partial thromboplastin time (aPTT). Notwithstanding, thromboelastography gives data with respect to all segments of hemostasis, for example, coagulation and platelet work. Likewise, TEG offers a specific benefit in diagnosing fibrinolysis. TEG machines are utilized for concluding this test. Thromboelastography and its later adjustment rotational thromboelastometry have their start during the 1940s as one of the first measures to evaluate the hemostatic status of patients.
Market Dynamics:
The TEG 5000 and TEG 6S Thromboelastograph Hemostasis Analyzers (Haemonetics) and the ROTEM (IL-Werfen) are worldwide entire blood analyzers that action coagulating time and the elements of cluster development and disintegration as affected by the energy of thrombin age, platelet initiation, fibrin age, clump strength, clump security, and inhibitory impacts on any perspective. These manual coagulometers utilized essentially in liver medical procedure, heart medical procedure, and trauma. Thromboelastography (TEG 5000, Haemonetics, Braintree, MA) and related rotational thromboelastometry (ROTEM, TEM Innovations, and Munich, Germany) are planned as place of-care tests to evaluate worldwide hemostasis in entire blood in the setting of injury or medical procedure. The tests measure the rotational shear power applied by the coagulated entire blood test to a pin connected to a locator.
Coronavirus contaminated patients might confront a high danger of creating kidney problems, stroke, and different intricacies related with development of blood clots. As indicated by the specialists from the University of Colorado Anschutz Medical Campus, Aurora, early thromboelastography (TEG) measure might be helpful to recognize COVID-19 patients who might require more anticoagulation treatment to forestall entanglements because of blood clot formation. It is suggested that all patients with COVID-19 ought to go through coagulation learns at confirmation, as there is critical expansion in D-dimer and prothrombin with a lessening in fibrinogen saw in COVID-19 patients who are at high danger (non-survivors at days 10-14). This is relied upon to speed up the utilization of coagulopathy screening test including thromboelastography (TEG) measure and other customary coagulation tests in the clinical setting.
North Аmеrіса ассоuntѕ for hіghеѕt rеvеnuе ѕhаrе in the global thromboelastography (TEG) market currently. Іn 2024, the North Аmеrіса market іѕ ехресtеd tо ассоunt fоr а rеvеnuе оf UЅ$ 237.5 Мn, аnd іѕ рrојесtеd tо rеgіѕtеr а rоbuѕt САGR оvеr thе fоrесаѕt реrіоd. Middle East and Africa thromboelastography (TEG) mаrkеt ассоuntеd fоr а rеvеnuе оf UЅ$ 30.8 Мn in 2022, аnd іѕ рrојесtеd tо rеgіѕtеr а САGR of about 6.0% оvеr thе 10-уеаr fоrесаѕt реrіоd.
Industry Developments:
Year 2021: New Products; Shenzhen Carewell Electronics Co., Ltd., a subsidiary of Lepu Medical launched its new ECG tablets–Neo ECG T180 and Neo ECG S120. Supporting connection with AI-ECG Platform, Neo ECG allows the hospitals and medical centers to achieve an intelligent diagnosis. This marks Lepu’s solid step towards AI-powered solutions.
Year 2017: Werfen and its subsidiary Instrumentation Laboratory (IL) announced the acquisition of Accriva Diagnostics, a global leader in in vitro diagnostic (IVD) blood testing at the Point-of-Care (POC), including its flagship product portfolio spanning coagulation, platelet aggregation, CO-Oximetry and incision devices.
Year 2017: The Stago group announced that it has completed the acquisition of HemoSonics LLC, a company specialized in the development of innovative Point-of-Care testing solutions based in Charlottesville, VA, with facilities in Durham, NC US.
Major Strategies adopted by key market players:
- Agreements, Collaborations, and Partnerships: 34%
- Acquisitions: 12%
- New Service Launch: _%
- Other Developments: _%
Scope of the Report:
Global Thromboelastography (TEG) Market, by Component
- Devices
- Single and Double Channel
- Four Channels
- Other Channel Types
- Consumables/ Disposables
Global Thromboelastography (TEG) Market, by Application
- Cardio-pulmonary Bypass Surgery
- Trauma
- Liver Transplantation
- Obstetrics
- Neonatolofy and Pediatrics
- Other Application
Global Thromboelastography (TEG) Market, by End-User
- Hospitals
- Maternal and Child Health Service
- Laboratory
- Other End Users
Global Thromboelastography (TEG) Market, by Geography
-
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe (RoE)
-
- China
- Japan
- India
- Rest of APAC (RoAPAC)
-
- Brazil
- Argentina
- Rest of South America
-
- GCC
- Israel
- South Africa
- Rest of MEA
Competitors landscape:
*The report scope shall be customized as per the requirements
Chapter 1 Global Thromboelastography (TEG) Market Overview
1.1 Introduction
1.2 Drivers for Thromboelastography (TEG) Market
1.3 Restraints for Thromboelastography (TEG) Market
1.4 Opportunities for Thromboelastography (TEG) Market
1.5 Trends for Thromboelastography (TEG) Market
1.6 Macro-economic Factors
1.7 Regulatory Framework
1.8 Opportunity Map Analysis
1.9 Opportunity Orbits
1.10 Market Investment Feasibility Index
1.11 PEST Analysis
1.12 PORTER’S Five Force Analysis
1.13 Go to Market Strategy
1.14 Marketing Strategy
1.15 Technology Roadmap
1.16 Advances in product/services adoption worldwide
1.17 Regional Market Share and BPS Analysis
Chapter 2 Global Thromboelastography (TEG) Market Competitive Analysis
2.1 Market Competition Scenario Analysis, By Company
2.2 Competitor Landscape
2.3 Major Strategies adopted by key market players (2020-2022)
2.4 Recent Developments/Investments/Announcements
2.5 Company Profiles
2.5.1 Haemonetics
2.5.1.1 Company Overview
2.5.1.2 Business Description
2.5.1.3 Product Portfolio
2.5.1.4 Key Financials
2.5.1.5 Company Presence & Business Segment Analysis – 2022
2.5.1.6 Key Developments
2.5.1.7 SWOT Analysis
2.5.2 Lepu Technology
2.5.2.1 Company Overview
2.5.2.2 Business Description
2.5.2.3 Product Portfolio
2.5.2.4 Key Financials
2.5.2.5 Company Presence & Business Segment Analysis – 2022
2.5.2.6 Key Developments
2.5.2.7 SWOT Analysis
2.5.3 Biomart
2.5.3.1 Company Overview
2.5.3.2 Business Description
2.5.3.3 Product Portfolio
2.5.3.4 Key Financials
2.5.3.5 Company Presence & Business Segment Analysis – 2022
2.5.3.6 Key Developments
2.5.3.7 SWOT Analysis
2.5.4 Medcaptain
2.5.4.1 Company Overview
2.5.4.2 Business Description
2.5.4.3 Product Portfolio
2.5.4.4 Key Financials
2.5.4.5 Company Presence & Business Segment Analysis – 2022
2.5.4.6 Key Developments
2.5.4.7 SWOT Analysis
2.5.5 Ud-bio
2.5.5.1 Company Overview
2.5.5.2 Business Description
2.5.5.3 Product Portfolio
2.5.5.4 Key Financials
2.5.5.5 Company Presence & Business Segment Analysis – 2022
2.5.5.6 Key Developments
2.5.5.7 SWOT Analysis
2.5.6 Chongqing Nanfang
2.5.6.1 Company Overview
2.5.6.2 Business Description
2.5.6.3 Product Portfolio
2.5.6.4 Key Financials
2.5.6.5 Company Presence & Business Segment Analysis – 2022
2.5.6.6 Key Developments
2.5.6.7 SWOT Analysis
2.5.7 WITEYE
2.5.7.1 Company Overview
2.5.7.2 Business Description
2.5.7.3 Product Portfolio
2.5.7.4 Key Financials
2.5.7.5 Company Presence & Business Segment Analysis – 2022
2.5.7.6 Key Developments
2.5.7.7 SWOT Analysis
2.5.8 Render
2.5.8.1 Company Overview
2.5.8.2 Business Description
2.5.8.3 Product Portfolio
2.5.8.4 Key Financials
2.5.8.5 Company Presence & Business Segment Analysis – 2022
2.5.8.6 Key Developments
2.5.8.7 SWOT Analysis
2.5.9 Guizhou Jinjiu Biotech
2.5.9.1 Company Overview
2.5.9.2 Business Description
2.5.9.3 Product Portfolio
2.5.9.4 Key Financials
2.5.9.5 Company Presence & Business Segment Analysis – 2022
2.5.9.6 Key Developments
2.5.9.7 SWOT Analysis
2.5.10 Chongqing Dingrun
2.5.10.1 Company Overview
2.5.10.2 Business Description
2.5.10.3 Product Portfolio
2.5.10.4 Key Financials
2.5.10.5 Company Presence & Business Segment Analysis – 2022
2.5.10.6 Key Developments
2.5.10.7 SWOT Analysis
Chapter 3 Global Thromboelastography (TEG) Market Overview
3.1 Global Thromboelastography (TEG) Market Outlook (2017-2032)
3.1.1 Global Thromboelastography (TEG) Market Value (US$ Mn) (2017-2023)
3.1.2 Global Thromboelastography (TEG) Market Value (US$ Mn) (2024-2032)
3.2 Global Thromboelastography (TEG) Market by Region
3.2.1 Global Thromboelastography (TEG) Market Value (US$ Mn) Comparison by Region (2017-2032)
3.2.2 Global Thromboelastography (TEG) Market Attractiveness Analysis by Region, 2023–2032
3.3 Global Thromboelastography (TEG) Market by Component
3.3.1 Global Thromboelastography (TEG) Market Value (US$ Mn) Comparison by Component (2017-2032)
3.3.2 Global Thromboelastography (TEG) Market Attractiveness Analysis by Component, 2023–2032
3.3.3 Global Thromboelastography (TEG) Market Attractiveness Analysis by Region, 2023–2032
3.4 Global Thromboelastography (TEG) Market by End User
3.4.1 Global Thromboelastography (TEG) Market Value (US$ Mn) Comparison by End User (2017-2032)
3.4.2 Global Thromboelastography (TEG) Market Attractiveness Analysis by End User, 2023–2032
3.5 Global Thromboelastography (TEG) Market Value (US$ Mn) by Region
3.5.1 Global Thromboelastography (TEG) Market Value (US$ Mn) Comparison by Region (2017-2023)
3.5.2 Global Thromboelastography (TEG) Market Value (US$ Mn) Comparison by Region (2024-2032)
3.6 Global Thromboelastography (TEG) Market Value (US$ Mn) by Component
3.6.1 Global Thromboelastography (TEG) Market Value (US$ Mn) Comparison by Component (2017-2023)
3.6.2 Global Thromboelastography (TEG) Market Value (US$ Mn) Comparison by Component (2024-2032)
3.7 Global Thromboelastography (TEG) Market Value (US$ Mn) by End User
3.7.1 Global Thromboelastography (TEG) Market Value (US$ Mn) Comparison by End User (2017-2023)
3.7.2 Global Thromboelastography (TEG) Market Value (US$ Mn) Comparison by End User (2024-2032)
3.8 Global Thromboelastography (TEG) Market Y-o-Y Growth Rate Comparison 2018–2032
3.8.1 Global Thromboelastography (TEG) Market Y-o-Y Growth Rate by Region
3.8.2 Global Thromboelastography (TEG) Market Y-o-Y Growth Rate by Component
3.8.3 Global Thromboelastography (TEG) Market Y-o-Y Growth Rate by End User
3.9 Global Thromboelastography (TEG) Market Share Comparison 2017–2032
3.9.1 Global Thromboelastography (TEG) Market Share by Region
3.9.2 Global Thromboelastography (TEG) Market Share by Component
3.9.3 Global Thromboelastography (TEG) Market Share by End User
Chapter 4 North America Thromboelastography (TEG) Market Overview
4.1 North America Market Snapshot
4.1.1 Regional Overview
4.1.1.1 US
4.1.1.2 Canada
4.1.1.3 Mexico
4.2 North America Thromboelastography (TEG) Market Outlook (2017-2032)
4.2.1 North America Thromboelastography (TEG) Market Value (US$ Mn) (2017-2023)
4.2.2 North America Thromboelastography (TEG) Market Value (US$ Mn) (2024-2032)
4.3 North America Thromboelastography (TEG) Market by Region
4.3.1 North America Thromboelastography (TEG) Market Value (US$ Mn) Comparison by Region (2017-2032)
4.3.2 North America Thromboelastography (TEG) Market Attractiveness Analysis by Region, 2023–2032
4.4 North America Thromboelastography (TEG) Market by Component
4.4.1 North America Thromboelastography (TEG) Market Value (US$ Mn) Comparison by Component (2017-2032)
4.4.2 North America Thromboelastography (TEG) Market Attractiveness Analysis by Component, 2023–2032
4.4.3 North America Thromboelastography (TEG) Market Attractiveness Analysis by Region, 2023–2032
4.5 North America Thromboelastography (TEG) Market by End User
4.5.1 North America Thromboelastography (TEG) Market Value (US$ Mn) Comparison by End User (2017-2032)
4.5.2 North America Thromboelastography (TEG) Market Attractiveness Analysis by End User, 2023–2032
4.6 North America Thromboelastography (TEG) Market Value (US$ Mn) by Region
4.6.1 North America Thromboelastography (TEG) Market Value (US$ Mn) Comparison by Region (2017-2023)
4.6.2 North America Thromboelastography (TEG) Market Value (US$ Mn) Comparison by Region (2024-2032)
4.7 North America Thromboelastography (TEG) Market Value (US$ Mn) by Component
4.7.1 North America Thromboelastography (TEG) Market Value (US$ Mn) Comparison by Component (2017-2023)
4.7.2 North America Thromboelastography (TEG) Market Value (US$ Mn) Comparison by Component (2024-2032)
4.8 North America Thromboelastography (TEG) Market Value (US$ Mn) by End User
4.8.1 North America Thromboelastography (TEG) Market Value (US$ Mn) Comparison by End User (2017-2023)
4.8.2 North America Thromboelastography (TEG) Market Value (US$ Mn) Comparison by End User (2024-2032)
4.9 North America Thromboelastography (TEG) Market Y-o-Y Growth Rate Comparison 2018–2032
4.9.1 North America Thromboelastography (TEG) Market Y-o-Y Growth Rate by Region
4.9.2 North America Thromboelastography (TEG) Market Y-o-Y Growth Rate by Component
4.9.3 North America Thromboelastography (TEG) Market Y-o-Y Growth Rate by End User
4.1 North America Thromboelastography (TEG) Market Share Comparison 2017–2032
4.10.1 North America Thromboelastography (TEG) Market Share by Region
4.10.2 North America Thromboelastography (TEG) Market Share by Component
4.10.3 North America Thromboelastography (TEG) Market Share by End User
Chapter 5 Europe Thromboelastography (TEG) Market Overview
5.1 Europe Market Snapshot
5.1.1 Regional Overview
5.1.1.1 Germany
5.1.1.2 United Kingdom
5.1.1.3 France
5.1.1.4 Italy
5.1.1.5 Spain
5.1.1.6 Russia
5.1.1.7 Rest of Europe
5.2 Europe Thromboelastography (TEG) Market Outlook (2017-2032)
5.2.1 Europe Thromboelastography (TEG) Market Value (US$ Mn) (2017-2023)
5.2.2 Europe Thromboelastography (TEG) Market Value (US$ Mn) (2024-2032)
5.3 Europe Thromboelastography (TEG) Market by Region
5.3.1 Europe Thromboelastography (TEG) Market Value (US$ Mn) Comparison by Region (2017-2032)
5.3.2 Europe Thromboelastography (TEG) Market Attractiveness Analysis by Region, 2023–2032
5.4 Europe Thromboelastography (TEG) Market by Component
5.4.1 Europe Thromboelastography (TEG) Market Value (US$ Mn) Comparison by Component (2017-2032)
5.4.2 Europe Thromboelastography (TEG) Market Attractiveness Analysis by Component, 2023–2032
5.4.3 Europe Thromboelastography (TEG) Market Attractiveness Analysis by Region, 2023–2032
5.5 Europe Thromboelastography (TEG) Market by End User
5.5.1 Europe Thromboelastography (TEG) Market Value (US$ Mn) Comparison by End User (2017-2032)
5.5.2 Europe Thromboelastography (TEG) Market Attractiveness Analysis by End User, 2023–2032
5.6 Europe Thromboelastography (TEG) Market Value (US$ Mn) by Region
5.6.1 Europe Thromboelastography (TEG) Market Value (US$ Mn) Comparison by Region (2017-2023)
5.6.2 Europe Thromboelastography (TEG) Market Value (US$ Mn) Comparison by Region (2024-2032)
5.7 Europe Thromboelastography (TEG) Market Value (US$ Mn) by Component
5.7.1 Europe Thromboelastography (TEG) Market Value (US$ Mn) Comparison by Component (2017-2023)
5.7.2 Europe Thromboelastography (TEG) Market Value (US$ Mn) Comparison by Component (2024-2032)
5.8 Europe Thromboelastography (TEG) Market Value (US$ Mn) by End User
5.8.1 Europe Thromboelastography (TEG) Market Value (US$ Mn) Comparison by End User (2017-2023)
5.8.2 Europe Thromboelastography (TEG) Market Value (US$ Mn) Comparison by End User (2024-2032)
5.9 Europe Thromboelastography (TEG) Market Y-o-Y Growth Rate Comparison 2018–2032
5.9.1 Europe Thromboelastography (TEG) Market Y-o-Y Growth Rate by Region
5.9.2 Europe Thromboelastography (TEG) Market Y-o-Y Growth Rate by Component
5.9.3 Europe Thromboelastography (TEG) Market Y-o-Y Growth Rate by End User
5.1 Europe Thromboelastography (TEG) Market Share Comparison 2017–2032
5.10.1 Europe Thromboelastography (TEG) Market Share by Region
5.10.2 Europe Thromboelastography (TEG) Market Share by Component
5.10.3 Europe Thromboelastography (TEG) Market Share by End User
Chapter 6 Asia Pacific Thromboelastography (TEG) Market Overview
6.1 Asia Pacific Market Snapshot
6.1.1 Regional Overview
6.1.1.1 China
6.1.1.2 India
6.1.1.3 Japan
6.1.1.4 Australia
6.1.1.5 Rest of Asia Pacific
6.2 Asia Pacific Thromboelastography (TEG) Market Outlook (2017-2032)
6.2.1 Asia Pacific Thromboelastography (TEG) Market Value (US$ Mn) (2017-2023)
6.2.2 Asia Pacific Thromboelastography (TEG) Market Value (US$ Mn) (2024-2032)
6.3 Asia Pacific Thromboelastography (TEG) Market by Region
6.3.1 Asia Pacific Thromboelastography (TEG) Market Value (US$ Mn) Comparison by Region (2017-2032)
6.3.2 Asia Pacific Thromboelastography (TEG) Market Attractiveness Analysis by Region, 2023–2032
6.4 Asia Pacific Thromboelastography (TEG) Market by Component
6.4.1 Asia Pacific Thromboelastography (TEG) Market Value (US$ Mn) Comparison by Component (2017-2032)
6.4.2 Asia Pacific Thromboelastography (TEG) Market Attractiveness Analysis by Component, 2023–2032
6.4.3 Asia Pacific Thromboelastography (TEG) Market Attractiveness Analysis by Region, 2023–2032
6.5 Asia Pacific Thromboelastography (TEG) Market by End User
6.5.1 Asia Pacific Thromboelastography (TEG) Market Value (US$ Mn) Comparison by End User (2017-2032)
6.5.2 Asia Pacific Thromboelastography (TEG) Market Attractiveness Analysis by End User, 2023–2032
6.6 Asia Pacific Thromboelastography (TEG) Market Value (US$ Mn) by Region
6.6.1 Asia Pacific Thromboelastography (TEG) Market Value (US$ Mn) Comparison by Region (2017-2023)
6.6.2 Asia Pacific Thromboelastography (TEG) Market Value (US$ Mn) Comparison by Region (2024-2032)
6.7 Asia Pacific Thromboelastography (TEG) Market Value (US$ Mn) by Component
6.7.1 Asia Pacific Thromboelastography (TEG) Market Value (US$ Mn) Comparison by Component (2017-2023)
6.7.2 Asia Pacific Thromboelastography (TEG) Market Value (US$ Mn) Comparison by Component (2024-2032)
6.8 Asia Pacific Thromboelastography (TEG) Market Value (US$ Mn) by End User
6.8.1 Asia Pacific Thromboelastography (TEG) Market Value (US$ Mn) Comparison by End User (2017-2023)
6.8.2 Asia Pacific Thromboelastography (TEG) Market Value (US$ Mn) Comparison by End User (2024-2032)
6.9 Asia Pacific Thromboelastography (TEG) Market Y-o-Y Growth Rate Comparison 2018–2032
6.9.1 Asia Pacific Thromboelastography (TEG) Market Y-o-Y Growth Rate by Region
6.9.2 Asia Pacific Thromboelastography (TEG) Market Y-o-Y Growth Rate by Component
6.9.3 Asia Pacific Thromboelastography (TEG) Market Y-o-Y Growth Rate by End User
6.1 Asia Pacific Thromboelastography (TEG) Market Share Comparison 2017–2032
6.10.1 Asia Pacific Thromboelastography (TEG) Market Share by Region
6.10.2 Asia Pacific Thromboelastography (TEG) Market Share by Component
6.10.3 Asia Pacific Thromboelastography (TEG) Market Share by End User
Chapter 7 South America Thromboelastography (TEG) Market Overview
7.1 South America Market Snapshot
7.1.1 Regional Overview
7.1.1.1 Brazil
7.1.1.2 Argentina
7.1.1.3 Rest of South America
7.2 South America Thromboelastography (TEG) Market Outlook (2017-2032)
7.2.1 South America Thromboelastography (TEG) Market Value (US$ Mn) (2017-2023)
7.2.2 South America Thromboelastography (TEG) Market Value (US$ Mn) (2024-2032)
7.3 South America Thromboelastography (TEG) Market by Region
7.3.1 South America Thromboelastography (TEG) Market Value (US$ Mn) Comparison by Region (2017-2032)
7.3.2 South America Thromboelastography (TEG) Market Attractiveness Analysis by Region, 2023–2032
7.4 South America Thromboelastography (TEG) Market by Component
7.4.1 South America Thromboelastography (TEG) Market Value (US$ Mn) Comparison by Component (2017-2032)
7.4.2 South America Thromboelastography (TEG) Market Attractiveness Analysis by Component, 2023–2032
7.4.3 South America Thromboelastography (TEG) Market Attractiveness Analysis by Region, 2023–2032
7.5 South America Thromboelastography (TEG) Market by End User
7.5.1 South America Thromboelastography (TEG) Market Value (US$ Mn) Comparison by End User (2017-2032)
7.5.2 South America Thromboelastography (TEG) Market Attractiveness Analysis by End User, 2023–2032
7.6 South America Thromboelastography (TEG) Market Value (US$ Mn) by Region
7.6.1 South America Thromboelastography (TEG) Market Value (US$ Mn) Comparison by Region (2017-2023)
7.6.2 South America Thromboelastography (TEG) Market Value (US$ Mn) Comparison by Region (2024-2032)
7.7 South America Thromboelastography (TEG) Market Value (US$ Mn) by Component
7.7.1 South America Thromboelastography (TEG) Market Value (US$ Mn) Comparison by Component (2017-2023)
7.7.2 South America Thromboelastography (TEG) Market Value (US$ Mn) Comparison by Component (2024-2032)
7.8 South America Thromboelastography (TEG) Market Value (US$ Mn) by End User
7.8.1 South America Thromboelastography (TEG) Market Value (US$ Mn) Comparison by End User (2017-2023)
7.8.2 South America Thromboelastography (TEG) Market Value (US$ Mn) Comparison by End User (2024-2032)
7.9 South America Thromboelastography (TEG) Market Y-o-Y Growth Rate Comparison 2018–2032
7.9.1 South America Thromboelastography (TEG) Market Y-o-Y Growth Rate by Region
7.9.2 South America Thromboelastography (TEG) Market Y-o-Y Growth Rate by Component
7.9.3 South America Thromboelastography (TEG) Market Y-o-Y Growth Rate by End User
7.1 South America Thromboelastography (TEG) Market Share Comparison 2017–2032
7.10.1 South America Thromboelastography (TEG) Market Share by Region
7.10.2 South America Thromboelastography (TEG) Market Share by Component
7.10.3 South America Thromboelastography (TEG) Market Share by End User
Chapter 8 Middle East and Africa Thromboelastography (TEG) Market Overview
8.1 Middle East and Africa Market Snapshot
8.1.1 Regional Overview
8.1.1.1 GCC
8.1.1.2 South Africa
8.1.1.3 Israel
8.1.1.4 Rest of Middle East and Africa
8.2 Middle East and Africa Thromboelastography (TEG) Market Outlook (2017-2032)
8.2.1 Middle East and Africa Thromboelastography (TEG) Market Value (US$ Mn) (2017-2023)
8.2.2 Middle East and Africa Thromboelastography (TEG) Market Value (US$ Mn) (2024-2032)
8.3 Middle East and Africa Thromboelastography (TEG) Market by Region
8.3.1 Middle East and Africa Thromboelastography (TEG) Market Value (US$ Mn) Comparison by Region (2017-2032)
8.3.2 Middle East and Africa Thromboelastography (TEG) Market Attractiveness Analysis by Region, 2023–2032
8.4 Middle East and Africa Thromboelastography (TEG) Market by Component
8.4.1 Middle East and Africa Thromboelastography (TEG) Market Value (US$ Mn) Comparison by Component (2017-2032)
8.4.2 Middle East and Africa Thromboelastography (TEG) Market Attractiveness Analysis by Component, 2023–2032
8.4.3 Middle East and Africa Thromboelastography (TEG) Market Attractiveness Analysis by Region, 2023–2032
8.5 Middle East and Africa Thromboelastography (TEG) Market by End User
8.5.1 Middle East and Africa Thromboelastography (TEG) Market Value (US$ Mn) Comparison by End User (2017-2032)
8.5.2 Middle East and Africa Thromboelastography (TEG) Market Attractiveness Analysis by End User, 2023–2032
8.6 Middle East and Africa Thromboelastography (TEG) Market Value (US$ Mn) by Region
8.6.1 Middle East and Africa Thromboelastography (TEG) Market Value (US$ Mn) Comparison by Region (2017-2023)
8.6.2 Middle East and Africa Thromboelastography (TEG) Market Value (US$ Mn) Comparison by Region (2024-2032)
8.7 Middle East and Africa Thromboelastography (TEG) Market Value (US$ Mn) by Component
8.7.1 Middle East and Africa Thromboelastography (TEG) Market Value (US$ Mn) Comparison by Component (2017-2023)
8.7.2 Middle East and Africa Thromboelastography (TEG) Market Value (US$ Mn) Comparison by Component (2024-2032)
8.8 Middle East and Africa Thromboelastography (TEG) Market Value (US$ Mn) by End User
8.8.1 Middle East and Africa Thromboelastography (TEG) Market Value (US$ Mn) Comparison by End User (2017-2023)
8.8.2 Middle East and Africa Thromboelastography (TEG) Market Value (US$ Mn) Comparison by End User (2024-2032)
8.9 Middle East and Africa Thromboelastography (TEG) Market Y-o-Y Growth Rate Comparison 2018–2032
8.9.1 Middle East and Africa Thromboelastography (TEG) Market Y-o-Y Growth Rate by Region
8.9.2 Middle East and Africa Thromboelastography (TEG) Market Y-o-Y Growth Rate by Component
8.9.3 Middle East and Africa Thromboelastography (TEG) Market Y-o-Y Growth Rate by End User
8.1 Middle East and Africa Thromboelastography (TEG) Market Share Comparison 2017–2032
8.10.1 Middle East and Africa Thromboelastography (TEG) Market Share by Region
8.10.2 Middle East and Africa Thromboelastography (TEG) Market Share by Component
8.10.3 Middle East and Africa Thromboelastography (TEG) Market Share by End User
Chapter 9 Methodology and Data Source
9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources
